LC–MS/MS determination of buparlisib, a phosphoinositide 3 kinase inhibitor in rat plasma: Application to a pharmacokinetic study-Reference-Cited by-同舟云学术

LC–MS/MS determination of buparlisib, a phosphoinositide 3 kinase inhibitor in rat plasma: Application to a pharmacokinetic study

Published:2020-03-16 Issue:6 Volume:34 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Wang Jingyun¹,Ming Meng²,Yu Lin¹,Chen Guangliang³,Hao Nan³,Meng Yuqi⁴,Fang Lina⁴^ORCID

Affiliation:

1. College of Public HealthShenyang Medical College Shenyang China

2. Office of Academic AffairsShenyang Medical College Shenyang China

3. College of Basic Medical ScienceShenyang Medical College Shenyang China

4. College of PharmacyShenyang Medical College Shenyang China

Funder

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.4816

Reference17 articles.

1. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial

2. A phase-1, open-label, single-dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairment

3. Department of Health and Human Services US Food and Drug Administration. (2018)Guidance for Industry—Bioanalytical Method Validation.https://www.fda.gov/media/70858/download

4. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

5. Targeting PI3K signalling in cancer: opportunities, challenges and limitations

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a UPLC-MS/MS Method for the Quantification of VS-5584 and Its Application in Pharmacokinetic Studies in Rats;Journal of Analytical Methods in Chemistry;2020-12-16